<DOC>
	<DOCNO>NCT01383460</DOCNO>
	<brief_summary>50 patient Acute-on-chronic liver failure ( ACLF ) enrol randomize G-CSF+EPO Placebo arm Treatment protocol To administer G-CSF ( prefilled syringe ) dose 5 µg/kg s/c day 1 , 2 , 3 , 4 , 5 every 3rd day till day 28 ( total 12 dos ) , along Darbopoetin alpha 100 mcg/ week ( prefilled syringe ) 4 week ( total 4 dos ) . Standard medical therapy include per requirement lactulose , bowel wash , albumin , terlipressin , antibiotic ( indicate ) continue record . Pentoxiphylline alcoholic hepatitis Tenofovir Hep B reactivation Controls : Standard medical therapy give along placebo similar prefilled syrinx . Follow Physical examination do daily , 1 week 4 week , 2 month , 3 month 6 month CBC alternate day 1 week , end 1 week end 4 week , 2 month , 3 month 6 month KFT alternate day 1 week , end 1 week end 4 week , 2 month , 3 month 6 month LFT along PT/INR alternate day 1 week , end 1 week end 4 week , 2 month , 3 month 6 month AFP baseline , 4 week , 3 month 6 month Liver regenerative potential efficacy test baseline 4 week</brief_summary>
	<brief_title>Efficacy Granulocyte Colony-stimulating Factor Erythropoetin Patients With Acute-on-chronic Liver Failure</brief_title>
	<detailed_description>50 patient ACLF enrol randomize G-CSF+EPO Placebo arm Baseline investigation : - Hematology - CBC , Prothrombin time INR - Peripheral smear , Retics - Biochemistry - Liver function testing , AFP - Kidney function test - Etiology acute event : - Infectious etiology : IgM anti HAV , IgM anti HEV , IgM anti HBc ( If HBsAg +ve ) , IgM anti HDV ( If HBsAg +ve ) , HEV RNA - Non Infectious etiology : Alcohol binge last 4 week , hepatotoxic drug , ANA ( &gt; 1 : 80 ) , IgG , surgeries past 4 week , acute variceal bleed within 4 week - Etiology underlie chronic liver disease : - Infectious etiology : total antiHBc , anti HCV , HCV RNA , HBV DNA - Non infectious etiology : Autoimmune marker , copper study , iron study , HOMA IR , FBS Ascitic fluid analysis ( wherever possible ) UGI endoscopy Imaging USG abdomen Doppler spleno-portal axis CECT- Triple phase upper abdomen Liver regenerative potential efficacy test ( wherever possible ) Histology ( transjugular liver biopsy ) Liver Dendritic cell ( CD11c , CD40 , CD 54 , CD 123 , BDCA 2 staining ) flow cytometry CD 34+ cell CD 133+ cell measurement hepatic venous blood , peripheral blood liver biopsy flow cytometry Markers proliferation like ki- 67 , proliferate cell nuclear antigen ( PCNA ) hepatic venous blood liver biopsy Markers angiogenesis like VEGF , v WF hepatic venous blood Measurement Hepatic venous pressure gradient ( HVPG ) Treatment protocol To administer G-CSF ( prefilled syringe ) dose 5 µg/kg s/c day 1 , 2 , 3 , 4 , 5 every 3rd day till day 28 ( total 12 dos ) , along Darbopoetin alpha 100 mcg/ week ( prefilled syringe ) 4 week ( total 4 dos ) . Standard medical therapy include per requirement lactulose , bowel wash , albumin , terlipressin , antibiotic ( indicate ) continue record . Pentoxiphylline alcoholic hepatitis Tenofovir Hep B reactivation Controls : Standard medical therapy give along placebo similar prefilled syrinx . Follow Physical examination do daily , 1 week 4 week , 2 month , 3 month 6 month CBC alternate day 1 week , end 1 week end 4 week , 2 month , 3 month 6 month KFT alternate day 1 week , end 1 week end 4 week , 2 month , 3 month 6 month LFT along PT/INR alternate day 1 week , end 1 week end 4 week , 2 month , 3 month 6 month AFP baseline , 4 week , 3 month 6 month Liver regenerative potential efficacy test baseline 4 week</detailed_description>
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>End Stage Liver Disease</mesh_term>
	<mesh_term>Acute-On-Chronic Liver Failure</mesh_term>
	<mesh_term>Liver Failure , Acute</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>All consecutive patient acute hepatic insult manifest jaundice ( Sr. Bil . ≥ 5 mg/dL ) coagulopathy ( INR≥1.5 ) , complicate within 4 week ascites and/or encephalopathy patient previously diagnose undiagnosed chronic liver disease Age &lt; 12 &gt; 75 year Autoimmune disorder HCC Sepsis ( Any culture positive : blood , urine , obvious source infection : UTI , SBP ) Multi organ failure Grade 4 HE HIV seropositivity / pregnancy Essential Hypertension Patients take transplant Refusal participate study</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Acute-on-chronic liver failure</keyword>
	<keyword>ACLF</keyword>
	<keyword>cirrhosis</keyword>
	<keyword>acute hepatitis</keyword>
</DOC>